About this course

  • Released: 12/3/2013
  • Expires: 12/3/2016

De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)

LEARNING OBJECTIVES:

Upon completion of the article by Karle et al, the participant should be able to:

  • Discuss the typical clinical and imaging findings and prognosis in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)
  • State the inheritance pattern and genetic defect causing HDLS

  • Discuss the pathologic findings of HDLS

CORE COMPETENCIES:

The article by Karle et alcovers the following core competency:

  • Medical Knowledge

Practice variability in brain death determination: A call to action

LEARNING OBJECTIVES:

Upon completion of the article by Shappell et al, the participant should be able to discuss:

  • Recognize that previous studies have shown variability in hospital policies pertaining to the assessment for brain death, but no previous study has carefully assessed for variability in approaches to brain death determination in practice
  • Discuss the findings from this study regarding variability of documentation of brain death determination, likely reflecting variability in practice and in conformation to published guidelines
  • Discuss the importance of improved documentation and better uniformity of policies pertaining to the determination of brain death

CORE COMPETENCIES:

The article by Shappellet alcovers the following core competency:

  • Medical Knowledge

AUTHOR DISCLOSURES

Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

Content failed to load, please try again later.

ACCME